{"url":"https://lda.senate.gov/api/v1/filings/46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec/","filing_uuid":"46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2025,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec/print/","filing_document_content_type":"text/html","income":null,"expenses":"20000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Benjamin A Novak","dt_posted":"2025-09-29T15:58:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1000 First Avenue","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"King of Prussia","registrant_state":"PA","registrant_zip":"19406","registrant":{"id":401109327,"url":"https://lda.senate.gov/api/v1/registrants/401109327/","house_registrant_id":66886,"name":"PARATEK PHARMACEUTICALS","description":null,"address_1":"1000 First Avenue","address_2":"Suite 200","address_3":null,"address_4":null,"city":"King of Prussia","state":"PA","state_display":"Pennsylvania","zip":"19406","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BENJAMIN NOVAK","contact_telephone":"+1 657-600-1827","dt_updated":"2026-06-26T10:03:51.205283-04:00"},"client":{"id":64825,"url":"https://lda.senate.gov/api/v1/clients/64825/","client_id":64825,"name":"PARATEK PHARMACEUTICALS","general_description":"Pharmaceuticals - Antibiotics & Biodefense","client_government_entity":null,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-03-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding","foreign_entity_issues":"Private Equity firm investment in the company.","lobbyists":[{"lobbyist":{"id":148979,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"NOVAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}